AMCY ACS Global Inc (CE)

American CryoStem Corporation (PINKSHEETS: AMCY) announced today that at the open of business June 15, 2011, the name change of American CryoStem Corporation to ACS Global, Inc. will take effect. The Company will retain its current symbol AMCY.PK.

Mr. Anthony Dudzinski, CEO, stated, "We are excited to complete this name change as the final step in our transaction with R & A Productions, Inc. ACS Global will continue to explore opportunities globally to secure and expand its position within the stem cell and regenerative medicine industry."

About ACS Global, Inc.: ACS Global, Inc. is the controlling shareholder of American CryoStem Corporation, and develops new technologies internally and through strategic relationships in the rapidly developing regenerative medicine and stem cell industry.

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the Company is detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

For More Information, contact: Investor Relations American CryoStem Corporation 188 East Bergen Place, Suite 204 Red Bank, NJ 07701 Phone:732-747-1007 Fax: 732-747-7782 www.americancryostem.com